The impact of COVID-19 on prescribing of pancreatic enzyme replacement therapy for people with unresectable pancreatic cancer in England. A cohort study using OpenSafely-TPP.

Agnieszka Lemanska Colm D Andrews Louis FisherBen Butler-ColeAmir MehrkarKeith J RobertsAlex J WalkerAlex J Walkernull nullBrian MacKenna

Published in: medRxiv : the preprint server for health sciences (2022)

Research is needed to understand barriers to prescribing of PERT.Our automated audit will allow regular data updates for the evaluation of healthcare interventions to improve prescribing of PERT.

Keyphrases

primary care
replacement therapy
healthcare
coronavirus disease
adverse drug
sars cov
smoking cessation
machine learning
physical activity
electronic health record
deep learning
high throughput
locally advanced
emergency department
squamous cell carcinoma
health information
data analysis
affordable care act